The triple-receptor approach is a huge leap beyond what semaglutide accomplishes with GLP-1 alone, providing avenues to manage weight loss and introducing considerations
Gu J, Liu J, Huang T, Zhang W, Jia B, Mu N, Zhang K, Hao Q, Li W, Liu W, Zhang W, Zhang Y, Xue X, Zhang C, Li M (2018) The protective and anti-inflammatory effects of a modified glucagon-like peptide-2 dimer in inflammatory bowel disease
GLP-1 provides systemic metabolic benefits: Reduced Visceral Fat: GLP-1 preferentially mobilizes harmful visceral adiposity (fat around organs), which drives inflammation and cardiometabolic disease
Furthermore, NCOA4 suppression prevented the rise in SFXN1 expression brought on by apelin-13
Several safety questions still need to be fully answered before retatrutide can be used routinely
92,96,100,103 In addition, it is also efficacious in the treatment of solid tumors, such as breast cancer, 102,104 lung cancer, 97,103,105 glioma, 103,106 prostate cancer, 107 kidney cancer, 108 bladder cancer, 109 colon cancer, 110 and hepatocellular carcinoma